Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer

Bibliographic Details
Main Authors:	Truin, W., Vugts, G., Roumen, R. M. H., Maaskant-Braat, A. J. G., Nieuwenhuijzen, G. A. P., van der Heiden-van der Loo, M., Tjan-Heijnen, V. C. G., Voogd, A. C.
Format:	Online
Language:	English
Published:	Springer US 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695495/

Similar Items

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
by: Delpech, Y, et al.
Published: (2013)

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
by: Lee, A. H., et al.
Published: (1996)

Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer
by: Wink, C. J., et al.
Published: (2011)

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review
by: Lobbes, M. B. I., et al.
Published: (2013)

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
by: Dixon, A. R., et al.
Published: (1991)

The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches
by: Lobbezoo, Dorien, et al.
Published: (2016)

PB.04: MRI In lobular and mixed lobular/ductal carcinomas: can we preselect cases based on imaging appearance?
by: Hoosein, MM, et al.
Published: (2013)

Histopathological and clonal study of combined lobular and ductal carcinoma of the breast
by: Tazaki, Eri, et al.
Published: (2013)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
by: Engels, C C, et al.
Published: (2014)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
by: Chiappa, A, et al.
Published: (2007)

Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?
by: Sankaye, P, et al.
Published: (2012)

MRI characteristics of lobular carcinoma of the breast
by: Leaver, A, et al.
Published: (2011)

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
by: Rigter, L S, et al.
Published: (2013)

PB.40. What happens to the ductal carcinoma in situ in HER2-positive cancers treated with neoadjuvant chemotherapy and trastuzumab?
by: Millican-Slater, R, et al.
Published: (2014)

p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast
by: Ercan, Cigdem, et al.
Published: (2012)

Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.
by: Toikkanen, S., et al.
Published: (1997)

Clinical management of women with metastatic breast cancer: a descriptive study according to age group
by: Manders, Klaartje, et al.
Published: (2006)

Systemic sclerosis presenting as lobular panniculitis
by: Binesh, V. G., et al.
Published: (2012)

The Expression of the Zonula Adhaerens Protein PLEKHA7 Is Strongly Decreased in High Grade Ductal and Lobular Breast Carcinomas
by: Tille, Jean-Christophe, et al.
Published: (2015)

The Myoepithelial Cell Layer May Serve As a Potential Trigger Factor for Different Outcomes of Stage-Matched Invasive Lobular and Ductal Breast Cancers
by: Yi-Hsuan Hsiao, Horng-Der Tsai, Ming-Chih Chou, Yan-gao Man
Published: (2011-01-01)

p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice
by: Tenhagen, Milou, et al.
Published: (2016)

Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population
by: Cao, A-Yong, et al.
Published: (2012)

A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer
by: van de Schoot, L., et al.
Published: (2007)

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions
by: Cowan, N. G., et al.
Published: (2014)

Neoadjuvant Chemotherapy in Invasive Bladder Cancer
by: Oliver, R.T.D.
Published: (1991)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
by: Jiang, Hui, et al.
Published: (2013)

Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
by: Wysocka, Olga, et al.
Published: (2016)

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
by: de Groot, S., et al.
Published: (2015)

Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods
by: Oliveira, Tatiane M. G., et al.
Published: (2014)

In Situ Malignant Transformation and Progenitor-Mediated Cell Budding: Two Different Pathways for Breast Ductal and Lobular Tumor Invasion
by: Man, Yan-gao, et al.
Published: (2011)

Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis
by: Turashvili, Gulisa, et al.
Published: (2007)

Relevance of systems biological approach in the differential diagnosis of invasive lobular carcinoma & invasive ductal carcinoma
by: Ragunath, PK, et al.
Published: (2012)

E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
by: Cleton-Jansen, Anne-Marie
Published: (2002)

Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
by: Jung, Seung Pil, et al.
Published: (2012)

Comparison of the Subgross Distribution of the Lesions in Invasive Ductal and Lobular Carcinomas of the Breast: A Large-Format Histology Study
by: Hofmeyer, Syster, et al.
Published: (2012)

In Situ Malignant Transformation and Progenitor-Mediated Cell Budding: Two Different Pathways for Breast Ductal and Lobular Tumor Invasion
by: Yan-gao Man, Mina Izadjoo, Guohong Song, Alexander Stojadinovic
Published: (2011-01-01)

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
by: Adachi, Yayoi, et al.
Published: (2016)

Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast
by: Park, Jun Su, et al.
Published: (2015)

Expression of Sarcosine Metabolism-Related Proteins in Invasive Lobular Carcinoma: Comparison to Invasive Ductal Carcinoma
by: Cha, Yoon Jin, et al.
Published: (2015)

Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases
by: Cutuli, Bruno, et al.
Published: (2015)